Instil Bio Inc has a consensus price target of $15.29, established from looking at the 21 latest analyst ratings. The last 3 analyst ratings were released from Jefferies, HC Wainwright & Co., and HC Wainwright & Co. on April 12, 2024, March 25, 2024, and January 22, 2024. With an average price target of $15.67 between Jefferies, HC Wainwright & Co., and HC Wainwright & Co., there's an implied 45.87% upside for Instil Bio Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/12/2024 | TIL | Buy Now | Instil Bio | $10.74 | 2.42% | Jefferies | Kelly Shi | $5 → $11 | Downgrade | Buy → Hold | Get Alert |
03/25/2024 | TIL | Buy Now | Instil Bio | $10.74 | 67.6% | HC Wainwright & Co. | Mitchell Kapoor | → $18 | Reiterates | Buy → Buy | Get Alert |
01/22/2024 | TIL | Buy Now | Instil Bio | $10.74 | 67.6% | HC Wainwright & Co. | Mitchell Kapoor | $2 → $18 | Maintains | Buy | Get Alert |
01/19/2024 | TIL | Buy Now | Instil Bio | $10.74 | 402.79% | Baird | Jack Allen | → $54 | Reiterates | Outperform → Outperform | Get Alert |
01/17/2024 | TIL | Buy Now | Instil Bio | $10.74 | 402.79% | Baird | Jack Allen | $100 → $54 | Maintains | Outperform | Get Alert |
11/14/2023 | TIL | Buy Now | Instil Bio | $10.74 | -81.38% | HC Wainwright & Co. | Mitchell Kapoor | → $40 | Reiterates | Buy → Buy | Get Alert |
08/17/2023 | TIL | Buy Now | Instil Bio | $10.74 | -81.38% | HC Wainwright & Co. | Mitchell Kapoor | → $40 | Reiterates | Buy → Buy | Get Alert |
06/29/2023 | TIL | Buy Now | Instil Bio | $10.74 | -81.38% | HC Wainwright & Co. | Mitchell Kapoor | → $40 | Initiates | → Buy | Get Alert |
04/05/2023 | TIL | Buy Now | Instil Bio | $10.74 | -44.13% | Truist Securities | Asthika Goonewardene | → $120 | Reinstates | → Hold | Get Alert |
12/12/2022 | TIL | Buy Now | Instil Bio | $10.74 | -81.38% | Morgan Stanley | Vikram Purohit | $120 → $40 | Maintains | Equal-Weight | Get Alert |
11/17/2022 | TIL | Buy Now | Instil Bio | $10.74 | 30.35% | Baird | Jack Allen | $480 → $280 | Maintains | Outperform | Get Alert |
11/01/2022 | TIL | Buy Now | Instil Bio | $10.74 | -44.13% | Morgan Stanley | Vikram Purohit | $160 → $120 | Maintains | Equal-Weight | Get Alert |
11/01/2022 | TIL | Buy Now | Instil Bio | $10.74 | 123.46% | Baird | Jack Allen | $620 → $480 | Maintains | Outperform | Get Alert |
11/01/2022 | TIL | Buy Now | Instil Bio | $10.74 | — | Cowen & Co. | Yaron Werber | — | Downgrade | Outperform → Market Perform | Get Alert |
09/06/2022 | TIL | Buy Now | Instil Bio | $10.74 | 188.64% | Baird | Jack Allen | $680 → $620 | Maintains | Outperform | Get Alert |
08/24/2022 | TIL | Buy Now | Instil Bio | $10.74 | -25.51% | Morgan Stanley | Vikram Purohit | $180 → $160 | Maintains | Equal-Weight | Get Alert |
08/23/2022 | TIL | Buy Now | Instil Bio | $10.74 | 48.98% | Truist Securities | Robyn Karnauskas | $500 → $320 | Maintains | Buy | Get Alert |
06/06/2022 | TIL | Buy Now | Instil Bio | $10.74 | -16.2% | Morgan Stanley | Vikram Purohit | $280 → $180 | Maintains | Equal-Weight | Get Alert |
05/24/2022 | TIL | Buy Now | Instil Bio | $10.74 | 30.35% | Morgan Stanley | Vikram Purohit | $300 → $280 | Maintains | Equal-Weight | Get Alert |
The latest price target for Instil Bio (NASDAQ: TIL) was reported by Jefferies on April 12, 2024. The analyst firm set a price target for $11.00 expecting TIL to rise to within 12 months (a possible 2.42% upside). 8 analyst firms have reported ratings in the last year.
The latest analyst rating for Instil Bio (NASDAQ: TIL) was provided by Jefferies, and Instil Bio downgraded their hold rating.
There is no last upgrade for Instil Bio.
The last downgrade for Instil Bio Inc happened on April 12, 2024 when Jefferies changed their price target from $5 to $11 for Instil Bio Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Instil Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Instil Bio was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
While ratings are subjective and will change, the latest Instil Bio (TIL) rating was a downgraded with a price target of $5.00 to $11.00. The current price Instil Bio (TIL) is trading at is $10.74, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.